Physician profile
Eric E Smouha
NPI 1780644302
$5,186.63
in general payments reported to CMS, 2019-2025
27 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $452 · 2021: $311 · 2022: $486 · 2023: $934 · 2024: $691 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,810.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $946.08 | 2019-2024 | Adhear Professional Kit, Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Glaxosmithkline, LLC. | $641.06 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $612.62 | 2020-2025 | |
| Cochlear Americas | $452.85 | 2020-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Kaleo, INC. | $353.73 | 2019-2024 | Auvi-Q |
| Inspire Medical Systems, INC. | $268.32 | 2023-2025 | Inspire |
| Stryker Corporation | $256.67 | 2019-2023 | Clarifix Cryotherapy Device, Xpress Ent Dilation System, Scopis Ent |
| Medtronic, INC. | $250.01 | 2023-2025 | Propel, Sinuva, Stealthstation S8 Platform |
| Optinose US, INC. | $207.89 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $194.46 | 2019-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $144.81 | 2025 | |
| Aerin Medical INC. | $107.42 | 2024-2025 | |
| Integra Lifesciences Corporation | $90.34 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Alk-Abello, INC | $88.78 | 2019-2025 | Grastek, Odactra, Ragwitek |
| Intersect Ent, INC. | $77.31 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.25 | 2022 | |
| Neurent Medical Limited | $69.40 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Smith+Nephew, INC. | $55.53 | 2022-2023 | Rapid Rhino, Coblation, Tula |
| Hikma Pharmaceuticals USA | $50.50 | 2024 | Ryaltris |
| Amgen INC. | $49.59 | 2023 | Tezspire |
| Acclarent, INC | $45.29 | 2019-2023 | Trudi Nav Cable |
| Blueprint Medicines Corporation | $36.56 | 2023 | Ayvakit |
| Phadia US INC. | $34.20 | 2020-2024 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $23.95 | 2021 | |
| Aimmune Therapeutics, INC. | $21.66 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $20.76 | 2025 | Tezspire |
| Octapharma USA, INC. | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Smouha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.